查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827797

2025年全球口腔给药系统市场报告

Buccal Drug Delivery System Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，口腔给药系统市场规模强劲成长，从2024年的35.5亿美元成长至2025年的38.9亿美元，复合年增长率达9.5%。预测期内的成长可归因于早期给药创新、製药业的应用、临床研究和疗效、市场渗透策略以及针对特定疾病的应用。

预计未来几年口腔给药系统市场将快速成长，到2029年将达到58.8亿美元，复合年增长率为10.9%。预测期内的增长可归因于以患者为中心的给药方式、老年人口的增长、对标靶治疗、生技药品和肽类给药的需求、监管支持和核准以及研发投入。预测期内的主要趋势包括患者便利性和依从性、药物製剂的进步、慢性病的增多、儿科和老年护理的增加以及生物有效性的提高。

颊粘膜给药系统透过覆盖口腔的颊粘膜给药所需药物。此方法适用于粘膜和粘膜给药。黏膜给药旨在在黏膜上进行特异性部位的药物释放，而经粘膜渗透是指药物穿过黏膜屏障吸收进入体循环。

颊部给药系统的主要类型包括舌下、颊部片剂、含片和口腔喷雾。 「舌下」指颊部药物全身给药的给药途径。它们在医院、门诊中心和其他医疗机构中用于各种用途，包括疼痛管理、戒烟和心绞痛。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供颊部给药系统市场统计数据，包括颊部给药系统行业的全球市场规模、各地区市场份额、颊部给药系统市场份额的竞争对手、颊部给药系统细分市场的详细情况、市场趋势和商机，以及您在颊部给药系统行业取得成功所需的数据。本颊部给药系统市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供全面的观点。

未来五年的预测成长率为10.9%，较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接波及美国，导致来自瑞士和印度等主要地区的黏性聚合物薄膜和控制释放基质材料供应链中断，从而可能减少创新疼痛管理疗法的供应，并推高药品成本。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，这种影响可能会更加广泛。

慢性病的日益普及预计将推动未来口腔给药系统市场的成长。慢性病是指持续时间超过一年的健康问题，例如癌症、心臟病、中风、糖尿病和关节炎。这些疾病可以控制但无法治愈，是最常见的慢性病之一，需要持续的医疗照护和营养支持。口腔给药系统为黏膜和粘膜给药提供了一种有效且方便的方法，许多患有糖尿病和癌症等慢性病的患者都需要这种方法。例如，2023 年 9 月，总部位于瑞士的联合国专门机构世界卫生组织 (WHO) 报告称，非传染性疾病 (NCD) 或慢性病每年造成 4,100 万人死亡，占全球死亡人数的 74%。其中，心血管疾病导致死亡1,790万人，癌症导致死亡930万人，慢性呼吸道疾病导致死亡410万人，糖尿病导致死亡200万人。因此，慢性病盛行率的上升正在推动口腔给药系统市场的成长。

预计医院需求的不断增长将推动未来口腔给药系统市场的成长。医院是为病人和受伤者提供治疗、护理和服务的专门机构。在医院环境中，口腔给药系统具有快速药物吸收、增强病患顺从性、减少胃肠道副作用、控制药物释放等优势。例如，2023年5月，代表医院和医疗保健网路的美国医疗保健产业协会美国医院协会 (AHA) 报告称，医院总数从2022年的6,093家增加到2023年的6,129家。此外，2023年美国所有医院的住院总人数为34,011,386人次，高于2022年的33,356,853人次。因此，医院需求的不断增长正在推动口腔给药系统市场的成长。

颊部给药系统市场的主要企业专注于创造创新解决方案，例如斑块型干癣的口服治疗，以改善患者预后并增强药物传递。斑块型干癣的口服治疗涉及口服药物来控制和缓解这种慢性自体免疫疾病的症状。这种疾病的特征是皮肤细胞快速增殖，导致出现厚而红且鳞状的斑块。例如，2022 年 9 月，美国製药公司百时美施贵宝的 Sotyktu (deucravacitinib) 获得 FDA核准，这是一种用于治疗中度至斑块型干癣成人的口服治疗药物。这项核准标誌着近十年来该疾病的首个新型口服治疗方法，引入了一种新的作用机制—选择性抑制蛋白酪氨酸激酶2 (TYK2)。

口腔给药系统市场的公司正专注于新产品的推出以创造收益。例如，2023年2月，Arlak Biotech Private Limited推出了一款褪黑素口腔喷雾。褪黑素口腔喷雾可促进人体自然产生褪黑素，提供一种简单有效的改善睡眠品质的方法。此类产品类型满足了特定的医疗保健需求，促进了口腔给药系统市场的成长。

2023年4月，美国製药公司DifGen Pharmaceuticals LLC收购了Aveva Drug Delivery Services, Inc.。此次策略性收购增强了DifGen的研发和生产能力，旨在确保可靠地供应高品质、高性价比的药品。 Aveva Drug Delivery Services专注于口服给药系统，这与DifGen提供先进可靠的药物解决方案的目标一致。

颊部给药系统市场涵盖胰岛素、尼古丁、替Tizanidine定、曲坦类药物、硝苯地平、氟比洛芬、羧甲基纤维素钠、卡波姆、格列本脲、透明质酸和黄原胶等药物成分的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值也包括商品製造商提供的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球颊部给药系统：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球颊部给药系统市场：成长率分析
  • 全球口腔给药系统市场表现：规模与成长，2019-2024
  • 全球口腔给药系统市场预测：规模与成长，2024-2029，2034
  • 全球颊部给药系统：总目标市场（TAM）

第六章 市场细分

  • 全球口腔给药系统市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 舌下片
  • 颊片和锭剂
  • 口腔喷雾剂
  • 全球口腔给药系统市场应用、绩效及预测（2019-2024、2024-2029、2034）
  • 疼痛管理
  • 禁止抽烟
  • 心绞痛
  • 全球口腔给药系统市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊中心
  • 其他最终用户
  • 全球颊部给药系统市场：舌下细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 舌下片
  • 舌下含片
  • 全球口腔给药系统市场：按类型细分（口腔片剂及含片）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 颊片
  • 口服锭剂
  • 全球颊部给药系统市场：口腔喷雾剂细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 喷雾溶液
  • 喷雾凝胶

第七章 区域和国家分析

  • 全球口腔给药系统市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球口腔给药系统市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 颊部给药系统市场：竞争格局
  • 颊部给药系统市场：公司简介
    • Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
    • Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Catalent Inc.
  • Arx Limited Liability Company
  • BioDelivery Science International Incorporated
  • Cynapsus Therapeutics Incorporated
  • Endo Pharmaceuticals Public Limited Company
  • Medlab Clinical Ltd.
  • AstraZeneca PLC
  • F Hoffmann-La Roche Limited
  • Dr. Reddy's Laboratories Ltd.
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Novo Nordisk A/S
  • Ethypharm SAS
  • Applied Pharma Research SA
  • Sunovion Pharmaceuticals Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年口腔给药系统市场：提供新机会的国家
  • 2029年口腔给药系统市场：细分领域带来新机会
  • 2029年口腔给药系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22440u

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown strongly in recent years. It will grow from $3.55 billion in 2024 to $3.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.88 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.

The forecast of 10.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for mucoadhesive polymer films and controlled-release matrix materials, sourced from key regions such as Switzerland and India, which could lead to reduced availability of innovative pain management therapies and increased medication costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

The rising demand in hospitals is expected to drive the growth of the buccal drug delivery systems market in the future. Hospitals are specialized facilities that provide medical treatment, care, and services to individuals who are ill or injured. In hospital settings, buccal drug delivery systems offer benefits such as rapid drug absorption, enhanced patient compliance, reduced gastrointestinal side effects, and controlled drug release. For example, in May 2023, a report from the American Hospital Association (AHA), a US-based healthcare trade organization representing hospitals and healthcare networks, indicated that the total number of hospitals increased to 6,129, up from 6,093 in 2022. Additionally, total admissions across all U.S. hospitals rose to 34,011,386, compared to 33,356,853 in 2022. Thus, the increasing demand in hospitals is propelling the growth of the buccal drug delivery systems market.

Leading companies in the buccal drug delivery systems market are concentrating on creating innovative solutions, such as oral treatments for plaque psoriasis, to enhance patient outcomes and improve drug delivery efficacy. Oral treatments for plaque psoriasis involve administering medications by mouth to manage and relieve the symptoms of this chronic autoimmune disorder, which is characterized by the rapid proliferation of skin cells resulting in thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in nearly a decade, introducing a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. For instance, in February 2023, launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
  • 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
  • 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
  • Subsegments:
  • 1) By Sublingual: Sublingual Tablets; Sublingual Films
  • 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
  • 3) By Oral Sprays: Spray Solutions; Spray Gels
  • Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation; Catalent Inc.; Arx Limited Liability Company; BioDelivery Science International Incorporated; Cynapsus Therapeutics Incorporated; Endo Pharmaceuticals Public Limited Company; Medlab Clinical Ltd.; AstraZeneca PLC; F Hoffmann-La Roche Limited; Dr. Reddy's Laboratories Ltd.; Takeda Pharmaceutical Company Limited; Novartis AG; Novo Nordisk A/S; Ethypharm SAS; Applied Pharma Research SA; Sunovion Pharmaceuticals Inc.; Sanofi SA; Bayer AG; Adare Pharmaceuticals Inc.; NAPP Pharmaceutical Ltd.; Perrigo Company PLC; Reckitt Benckiser Group PLC; Teligent Pharma Inc.; Par Pharmaceutical Companies Inc.; Acorda Therapeutics Inc.; Opiant Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Buccal Drug Delivery System Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Buccal Drug Delivery System Market Growth Rate Analysis
  • 5.4. Global Buccal Drug Delivery System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Buccal Drug Delivery System Total Addressable Market (TAM)

6. Buccal Drug Delivery System Market Segmentation

  • 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sublingual
  • Buccal Tablets And Lozenges
  • Oral Sprays
  • 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Smoking Cessation
  • Angina Pectoris
  • 6.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Centers
  • Other End-Users
  • 6.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sublingual Tablets
  • Sublingual Films
  • 6.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • Buccal Lozenges
  • 6.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spray Solutions
  • Spray Gels

7. Buccal Drug Delivery System Market Regional And Country Analysis

  • 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

  • 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Buccal Drug Delivery System Market

  • 9.1. China Buccal Drug Delivery System Market Overview
  • 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Buccal Drug Delivery System Market

  • 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Buccal Drug Delivery System Market

  • 11.1. Japan Buccal Drug Delivery System Market Overview
  • 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Buccal Drug Delivery System Market

  • 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

  • 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Buccal Drug Delivery System Market

  • 14.1. South Korea Buccal Drug Delivery System Market Overview
  • 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

  • 15.1. Western Europe Buccal Drug Delivery System Market Overview
  • 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Buccal Drug Delivery System Market

  • 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Buccal Drug Delivery System Market

  • 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Buccal Drug Delivery System Market

  • 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Buccal Drug Delivery System Market

  • 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Buccal Drug Delivery System Market

  • 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

  • 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
  • 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Buccal Drug Delivery System Market

  • 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Buccal Drug Delivery System Market

  • 23.1. North America Buccal Drug Delivery System Market Overview
  • 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Buccal Drug Delivery System Market

  • 24.1. USA Buccal Drug Delivery System Market Overview
  • 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Buccal Drug Delivery System Market

  • 25.1. Canada Buccal Drug Delivery System Market Overview
  • 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Buccal Drug Delivery System Market

  • 26.1. South America Buccal Drug Delivery System Market Overview
  • 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Buccal Drug Delivery System Market

  • 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Buccal Drug Delivery System Market

  • 28.1. Middle East Buccal Drug Delivery System Market Overview
  • 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Buccal Drug Delivery System Market

  • 29.1. Africa Buccal Drug Delivery System Market Overview
  • 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

  • 30.1. Buccal Drug Delivery System Market Competitive Landscape
  • 30.2. Buccal Drug Delivery System Market Company Profiles
    • 30.2.1. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Buccal Drug Delivery System Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Arx Limited Liability Company
  • 31.3. BioDelivery Science International Incorporated
  • 31.4. Cynapsus Therapeutics Incorporated
  • 31.5. Endo Pharmaceuticals Public Limited Company
  • 31.6. Medlab Clinical Ltd.
  • 31.7. AstraZeneca PLC
  • 31.8. F Hoffmann-La Roche Limited
  • 31.9. Dr. Reddy's Laboratories Ltd.
  • 31.10. Takeda Pharmaceutical Company Limited
  • 31.11. Novartis AG
  • 31.12. Novo Nordisk A/S
  • 31.13. Ethypharm SAS
  • 31.14. Applied Pharma Research SA
  • 31.15. Sunovion Pharmaceuticals Inc.

32. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Recent Developments In The Buccal Drug Delivery System Market

35. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

  • 35.1 Buccal Drug Delivery System Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Buccal Drug Delivery System Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Buccal Drug Delivery System Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer